Recent update from the regulatory landscape in clinical data management
Date: September 24, 2026
On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.
You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections
Scroll down to the Pre-inspection documentation tab to find the:
- GCP inspection dossier template – Computerised Systems
- GCP inspection dossier clinical trial spreadsheet – Computerised Systems
- GGP inspection dossier checklist – Computerised Systems.
MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.
An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.
For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:
- Number of substantial protocol amendments/modifications
- Number of change controls
- How many of these change controls related to a protocol amendment/modification
The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.
Explore More News
Newsletter Committee: Meet Neha
The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee.
Neha shares . . .
Read More
Newsletter Committee: Meet Sylvain
The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .
Read More
Welcome VHypotenuse as a corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .
Read More
Newsletter Committee: Meet Marta
The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .
Read More
AI model trained on de-identified data from 57 million people
Researchers at UCL have trained an AI model using de-identified data from 57 million . . .
Read More
ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released
The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .
Read More
ICH E6(R3) Guideline reaches Step 4 of the ICH Process
ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025.
The guideline . . .
Read More
U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties
The U.S. Food and Drug Administration has issued its first guidance on the use of . . .
Read More
ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025
As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .
Read More
Audit Trail Review DMEG Update – New Guide
The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .
Read More
Risk Based Quality Management DMEG Update – Recent Discussions
This year our focus has switched away from generalised RBQM to applying risk-based . . .
Read More
Regulatory Considerations DMEG Update – September 2024
The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .
Read More
